LHFPL5
LHFPL tetraspan subfamily member 5 protein
Also known as: DFNB67, dJ510O8.8, LHPL5_HUMAN, MGC33835, Tmhs
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TAF8
- Gene
- LHFPL5
- Ensembl
- ENSG00000197753
- Chromosome
- 6
- Canonical length
- 219 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene is a member of the lipoma HMGIC fusion partner (LHFP) gene family, which is a subset of the superfamily of tetraspan transmembrane protein encoding genes. Mutations in this gene result in deafness in humans, and a mutation in a similar gene in mice results in deafness and vestibular dysfunction with severe degeneration of the organ of Corti. It is proposed to function in hair bundle morphogenesis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
219 residues, UniProt reviewed canonical sequence.
>Q8TAF8|LHFPL5
1 MVKLLPAQEA AKIYHTNYVR NSRAVGVMWG TLTICFSVLV MALFIQPYWI GDSVNTPQAG
61 YFGLFSYCVG NVLSSELICK GGPLDFSSIP SRAFKTAMFF VALGMFLIIG SIICFSLFFI
121 CNTATVYKIC AWMQLAAATG LMIGCLVYPD GWDSSEVRRM CGEQTGKYTL GHCTIRWAFM
181 LAILSIGDAL ILSFLAFVLG YRQDKLLPDD YKADGTEEVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LHFPL5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 17 nTPM
- epididymis: 12 nTPM
- pancreas: 11 nTPM
- retina: 7.2 nTPM
- skin: 6.7 nTPM
- lung: 3.6 nTPM
Single-cell type
- neutrophils: 92 nCPM
- pancreatic acinar cells: 66 nCPM
- epicardial cells: 59 nCPM
- basal keratinocytes: 58 nCPM
- suprabasal keratinocytes: 55 nCPM
- esophageal suprabasal cells: 48 nCPM
Immune cell
- neutrophil: 3.3 nTPM
- basophil: 2.8 nTPM
- naive B-cell: 0.8 nTPM
- plasmacytoid DC: 0.7 nTPM
- NK-cell: 0.6 nTPM
- classical monocyte: 0.5 nTPM
Brain region
- cerebral cortex: 39 nTPM
- cerebellum: 37 nTPM
- basal ganglia: 36 nTPM
- hypothalamus: 34 nTPM
- hippocampal formation: 33 nTPM
- white matter: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LHFPL5.
Disease | AllUniProt
Conditions LHFPL5 is implicated in, by any mechanism.
- Deafness, autosomal recessive, 67 (DFNB67) MIM:610265
Disease | GeneticClinVar
23 pathogenic / likely-pathogenic of 184 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive nonsyndromic hearing loss 67
- Hearing loss, autosomal recessive
- Ear malformation
- Autosomal recessive non-syndromic intellectual disability
- Deafness
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- auditory receptor cell stereocilium organization
- detection of mechanical stimulus involved in sensory perception
- detection of mechanical stimulus involved in sensory perception of sound
- monoatomic ion transport
- sensory perception of sound
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LHFPL5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LHFPL5 as an antibody target. Whether an autoantibody or antibody against LHFPL5 could matter depends on whether native LHFPL5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LHFPL5 is annotated at the cell surface, where native LHFPL5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LHFPL5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...